Department of Biological Sciences, Auburn University, 120 W. Samford Ave, Rouse Life Sciences Building, Auburn, AL 36849, USA.
Bioorg Med Chem. 2019 May 15;27(10):2149-2165. doi: 10.1016/j.bmc.2019.03.057. Epub 2019 Mar 30.
The increasing appreciation for the crucial roles of RNAs in infectious and non-infectious human diseases makes them attractive therapeutic targets. Coding and non-coding RNAs frequently fold into complex conformations which, if effectively targeted, offer opportunities to therapeutically modulate numerous cellular processes, including those linked to undruggable protein targets. Despite the considerable skepticism as to whether RNAs can be targeted with small molecule therapeutics, overwhelming evidence suggests the challenges we are currently facing are not outside the realm of possibility. In this review, we highlight the most recent advances in molecular techniques that have sparked a revolution in understanding the RNA structure-to-function relationship. We bring attention to the application of these modern techniques to identify druggable RNA targets and to assess small molecule binding specificity. Finally, we discuss novel screening methodologies that support RNA drug discovery and present examples of therapeutically valuable RNA targets.
越来越多的人认识到 RNA 在传染性和非传染性人类疾病中的关键作用,这使得它们成为有吸引力的治疗靶点。编码 RNA 和非编码 RNA 经常折叠成复杂的构象,如果能够有效地靶向这些构象,就有机会治疗性地调节许多细胞过程,包括与难以成药的蛋白质靶标相关的过程。尽管人们对小分子治疗药物是否可以靶向 RNA 存在相当大的怀疑,但压倒性的证据表明,我们目前面临的挑战并非不可能。在这篇综述中,我们强调了分子技术的最新进展,这些进展引发了对 RNA 结构-功能关系的理解的革命。我们提请注意将这些现代技术应用于鉴定可成药的 RNA 靶标和评估小分子结合特异性。最后,我们讨论支持 RNA 药物发现的新筛选方法,并介绍有治疗价值的 RNA 靶标的例子。